Cardiovascular disease

Primary Care - Clinics in Office Practice

Volumn 29, Issue 2, 2002, Pages 323-338

  Gavagan, Thomas ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; CARDIAC GLYCOSIDE; CHOLESTIN; CRATAEGUS EXTRACT; CYANOCOBALAMIN; DIGITALIS; DIGITOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPHEDRA EXTRACT; EPHEDRINE; FOLIC ACID; GARLIC EXTRACT; GLYCOSIDE; GUGGULSTERONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; OMEGA 3 FATTY ACID; PANAX NOTOGINSENG EXTRACT; PLANT EXTRACT; PYRIDOXINE; RAMIPRIL; RAUWOLFIA EXTRACT; RESERPINE; SALICIN; SALVIA MILTIORRHIZA EXTRACT; TRIGONELLA FOENUM GRAECUM EXTRACT; UBIQUINONE; UNINDEXED DRUG; VITAMIN; CHELATING AGENT; PLANT MEDICINAL PRODUCT;

ALTERNATIVE MEDICINE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHELATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CRATAEGUS; DIET; EXERCISE; FENUGREEK; GARLIC; HERBAL MEDICINE; HOMEOPATHY; HUMAN; LOW FAT DIET; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; VITAMIN SUPPLEMENTATION; CORONARY ARTERY DISEASE; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFESTYLE; METHODOLOGY; PATIENT EDUCATION; PHYTOTHERAPY; PRIMARY PREVENTION; UNITED STATES;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CHELATING AGENTS; COMPLEMENTARY THERAPIES; CORONARY DISEASE; HEART FAILURE, CONGESTIVE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFE STYLE; PATIENT EDUCATION; PHYTOTHERAPY; PLANT PREPARATIONS; PRIMARY PREVENTION; UNITED STATES; VITAMINS; HUMANS;

EID: 0036594047     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(01)00009-4     Document Type: Review

References (103)

1. Prevention of coronary artery disease
2. Integrative cardiac revitalization: Bypass surgery, angioplasty and chelation, benefits, risks and limitations
3. Effects of life-style modification of serum lipids
4. Lack of significant hormonal effects and controlled trials of phyto-oestrogens
5. Dubious benefits and potential risk of soy phyto-oestrogens
6. Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels
7. Conference summary from the Nutrition Committee of the American Heart Association: Summary of the scientific conference on dietary fatty acids and cardiovascular health
8. Can dietary interventions change diet and cardiovascular risk factors? A meta-analysis of randomized controlled trials
9. Coronary risk reduction through intensive community-based lifestyle intervention: The coronary health improvement project (CHIP) experience
10. Very low fat diets
11. A strategy to arrest and reverse coronary artery disease: A 5-year longitudinal study of a single physician's practice
12. Clinical debate: Should a low-fat, high carbohydrate diet be recommended for everyone? Beyond low-fat diets
13. Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers: The Honolulu Heart Program
14. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
15. Frequent nut consumption and risk of coronary heart disease in women: Prospective cohort study
16. Long-term intake of dietary fiber and decreased risk of coronary heart disease among women
17. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease?
18. Fruit and vegetables, and cardiovascular disease; a review
19. Double-blind study of the addition of high-protein soya milk v. cows' milk to the diet of patients with severe hypercholesterolaemia and resistance to or intolerance of statins
20. Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan
21. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women
22. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women
23. Retardation of coronary atherosclerosis with yoga lifestyle intervention
24. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects
25. Meta-analysis of the effects of soy protein intake on serum lipids
26. Food labeling, health claims, soy protein, and coronary heart disease
27. Soy protein and cardiovascular disease: A statement for healthcare professionals from the Nutrition Committee of the AMA
28. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement
29. Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: The Oslo Diet and Exercise Study
30. A clinical trial of the effects of dietary patterns on blood pressure
31. Fruit and vegetable intake in relation to risk of ischemic stroke
32. Whole grain consumption and risk of ischemic stroke in women
33. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet
34. Does vitamin E decrease heart attack risk? Summary and implications with respect to dietary recommendations
35. Vitamin E consumption and the risk of coronary disease in women
36. Vitamin E consumption and the risk of coronary heart disease in men
37. Lack of effect of long-term supplementation with betacarotene on the incidence of malignant neoplasms and cardiovascular disease
38. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
39. Effects of a combination of betacarotene and vitamin A on lung cancer and cardiovascular disease
40. The role of vitamin E in the prevention of heart disease
41. Vitamin E and coronary artery disease
42. Homocysteine and risk of cardiovascular disease among postmenopausal women
43. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins
44. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
45. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels
46. Association of hostility with coronary artery calcification in young adults: The Cardia study
47. Lack of correlation between psychological factors and subclinical coronary artery disease
48. The influence of anxiety and depression on outcomes of patients with coronary artery disease
49. Depression and 1-year prognosis in unstable angina
50. Social support, depression, and mortality during the first year after myocardial infarction
51. Usefulness of the transcendental meditation program in the treatment of patients with coronary artery disease
52. Effects of transcendental meditation on symptoms and electrocardiographic changes in patients with cardiac syndrome X
53. Stress, stress reduction and hypercholesterolemia in African Americans: A review
54. ABC of complementary medicine: Massage therapies
55. Mind-body therapy in the management and prevention of coronary disease
56. The effects of aerobic exercise and T'ai Chi on blood pressure in older people: Results of a randomized trial
57. Physical activity and coronary heart disease in men: The Harvard Alumni Health Study
58. Effects of lifestyle activity vs structured aerobic exercise in obese women: A randomized trial
59. Physical activity and 10-year mortality from cardiovascular diseases and all causes
60. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women
61. Physical activity and stroke incidence: The Harvard Alumni Health Study
62. Influence of psychosocial factors and biopsychosocial interventions on outcomes after myocardial infarction
63. Effects of relaxing music on cardiac autonomic balance and anxiety after acute myocardial infarction
64. Stress management and exercise training in cardiac patients with myocardial ischemia: Effects on prognosis and evaluation of mechanisms
65. Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction
66. Herbal medicine for the treatment of cardiovascular disease: Clinical considerations
67. Natural medicines comprehensive database 2000
68. Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris
69. Complementary and alternative medicine in cardiovascular disease: What is the evidence it works?
70. Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy
71. Alternative therapies: Part II. Congestive heart failure and hypercholesterolemia
72. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure
73. Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting
74. Crataegus oxyacantha and heart failure
75. Natural medicines comprehensive database 2000
76. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions
77. Survival and prognosis: Investigation of crataegus extract WS 1442 in congestive heart failure (SPICE) - Rationale, study design and study protocol
78. Garlic as a lipid-lowering agent: A meta-analysis
79. Effect of garlic on total serum cholesterol: A meta-analysis
80. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: A randomized controlled trial
81. Garlic powder and plasma lipids and lipoproteins: A multicenter, randomized, placebo-controlled trial
82. Garlic for treating hypercholesterolemia: A meta-analysis of randomized clinical trials
83. The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults
84. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density liipoprotein subclass distribution and lipoprotein(a)
85. Clinical trials with gugulipid: A new hypolipidaemic agent
86. Hypolipidemic and antioxidant effects of commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia
87. Effect of ginger and fenugreek on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease
88. Implication of steroid saponins and sapogenins in the hypocholesterolemic effect of fenugreek
89. A review of 12 commonly used medicinal herbs
90. Short-term economic and health benefits of smoking cessation: Myocardial infarction and stroke
91. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial
92. Intensive lifestyle changes for reversal of coronary heart disease
93. Avoiding revascularization with lifestyle changes: The Multicenter Lifestyle Demonstration Project
94. Clinical evaluation of chelation therapy: Is there any wheat amidst the chaff?
95. Chelation therapy for coronary heart disease: An overview of all clinical investigations
96. Inefficacy of EDTA chelation therapy for coronary atherosclerosis
97. Chelation therapy for intermittent claudication: A double-blind, randomized, controlled trial
98. The effects of soy protein in women and men with elevated plasma lipids